Litcius/Paper detail

Genetic and Molecular Evaluation of SQSTM1/p62 on the Neuropathologies of Alzheimer’s Disease

Wei Dong, Mengchao Cui, Wenzheng Hu, Qi Zeng, Yilong Wang, Wei Zhang, Yue Huang

2022Frontiers in Aging Neuroscience17 citationsDOIOpen Access PDF

Abstract

Sequestosome 1 ( SQSTM1 )/p62 is a multifunctional scaffolding protein and plays a major role in the cellular processes of autophagy, upregulation of which has been shown in several neurodegenerative disorders, including Alzheimer’s disease (AD). To investigate its genetic effects and relationship with AD pathologies, we analyzed the genetic associations of SQSTM1 rs4935 with the risk of AD and the levels of AD biomarkers using the AD Neuroimaging Initiative (ADNI) Database. We further analyzed the distribution pattern of p62 immunoreactivity in relation to AD pathologies in the postmortem human brain tissues from AD and non-AD controls. We found that SQSTM1 rs4935 was not associated with the risk of AD, but its T allele was significantly associated with decreased β-amyloid (1–42) (Aβ 42 ) levels in the cerebral spinal fluid (CSF) of patients with AD (β = −9.336, p = 0.022). In addition, p62 immunoreactivity in AD is increased, but it shows an inverse relationship to Aβ deposition. A small proportion of senile plaques show p62 positive neurites. Our results suggest that SQSTM1 /p62 may play an important role in the progression of AD via associations with Aβ 42 levels in CSF and Aβ deposition in the brain of patients with AD.

Topics & Concepts

Sequestosome 1Alzheimer's diseaseDiseaseSenile plaquesAlleleMedicinePathologyNeuroscienceAutophagyBiologyGeneGeneticsApoptosisAutophagy in Disease and TherapyAlzheimer's disease research and treatmentsParkinson's Disease Mechanisms and Treatments
Genetic and Molecular Evaluation of SQSTM1/p62 on the Neuropathologies of Alzheimer’s Disease | Litcius